These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2722864)

  • 21. Molecular characterization of antithrombin Barcelona-2: 47 arginine to cysteine.
    Owen MC; Shaw GJ; Grau E; Fontcuberta J; Carrell RW; Boswell DR
    Thromb Res; 1989 Aug; 55(4):451-7. PubMed ID: 2814937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P1 variant antithrombins Glasgow (393 Arg to His) and Pescara (393 Arg to Pro) have increased heparin affinity and are resistant to catalytic cleavage by elastase. Implications for the heparin activation mechanism.
    Owen MC; George PM; Lane DA; Boswell DR
    FEBS Lett; 1991 Mar; 280(2):216-20. PubMed ID: 2013315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
    Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.
    Griffith MJ; Noyes CM; Church FC
    J Biol Chem; 1985 Feb; 260(4):2218-25. PubMed ID: 3838304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT----TGT) and antithrombin III Glasgow (393 CGT----CAT).
    Thein SL; Lane DA
    Blood; 1988 Nov; 72(5):1817-21. PubMed ID: 3179448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a lysyl residue in antithrombin which is essential for heparin binding.
    Peterson CB; Noyes CM; Pecon JM; Church FC; Blackburn MN
    J Biol Chem; 1987 Jun; 262(17):8061-5. PubMed ID: 3110143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
    Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-directed mutagenesis of the P2 residue of human antithrombin.
    Sheffield WP; Blajchman MA
    FEBS Lett; 1994 Feb; 339(1-2):147-50. PubMed ID: 8313964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.
    Daly M; Bruce D; Perry DJ; Price J; Harper PL; O'Meara A; Carrell RW
    FEBS Lett; 1990 Oct; 273(1-2):87-90. PubMed ID: 1977621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain.
    Garbarz M; Lecomte MC; Féo C; Devaux I; Picat C; Lefebvre C; Galibert F; Gautero H; Bournier O; Galand C
    Blood; 1990 Apr; 75(8):1691-8. PubMed ID: 2328319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insertions/deletions in the antithrombin gene: 3 mutations associated with non-expression.
    Daly M; Perry DJ; Harper PL; Daly HM; Roques AW; Carrell RW
    Thromb Haemost; 1992 May; 67(5):521-5. PubMed ID: 1325679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial overexpression of beta antithrombin caused by an Asn135Thr substitution.
    Bayston TA; Tripodi A; Mannucci PM; Thompson E; Ireland H; Fitches AC; Hananeia L; Olds RJ; Lane DA
    Blood; 1999 Jun; 93(12):4242-7. PubMed ID: 10361121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation.
    Chuang YJ; Gettins PG; Olson ST
    J Biol Chem; 1999 Oct; 274(40):28142-9. PubMed ID: 10497166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.
    Owen MC; Borg JY; Soria C; Soria J; Caen J; Carrell RW
    Blood; 1987 May; 69(5):1275-9. PubMed ID: 3567355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family.
    Olds RJ; Lane DA; Caso R; Panico M; Morris HR; Sas G; Dawes J; Thein SL
    Blood; 1992 Mar; 79(5):1206-12. PubMed ID: 1536946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.
    Olds RJ; Lane DA; Boisclair M; Sas G; Bock SC; Thein SL
    FEBS Lett; 1992 Apr; 300(3):241-6. PubMed ID: 1555650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P1' residue in transition-state stabilization of antithrombin-proteinase complex formation.
    Olson ST; Stephens AW; Hirs CH; Bock PE; Björk I
    J Biol Chem; 1995 Apr; 270(17):9717-24. PubMed ID: 7730349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
    Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
    Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
    Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
    J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.